HK1177745A1 - 作為 酶抑制劑的雜芳基芳基三唑衍生物 - Google Patents

作為 酶抑制劑的雜芳基芳基三唑衍生物

Info

Publication number
HK1177745A1
HK1177745A1 HK13104921.1A HK13104921A HK1177745A1 HK 1177745 A1 HK1177745 A1 HK 1177745A1 HK 13104921 A HK13104921 A HK 13104921A HK 1177745 A1 HK1177745 A1 HK 1177745A1
Authority
HK
Hong Kong
Prior art keywords
pde10a
enzyme inhibitors
triazole derivatives
heteroaromatic aryl
aryl triazole
Prior art date
Application number
HK13104921.1A
Other languages
English (en)
Inventor
Ask Pschl
Jacob Nielsen
Jan Kehler
John Paul Kilburn
Mauro Marigo
Morten Langgrd
Original Assignee
‧隆德貝克有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ‧隆德貝克有限公司 filed Critical ‧隆德貝克有限公司
Publication of HK1177745A1 publication Critical patent/HK1177745A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK13104921.1A 2009-12-17 2013-04-23 作為 酶抑制劑的雜芳基芳基三唑衍生物 HK1177745A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200901340 2009-12-17
PCT/DK2010/050344 WO2011072697A1 (en) 2009-12-17 2010-12-15 Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors

Publications (1)

Publication Number Publication Date
HK1177745A1 true HK1177745A1 (zh) 2013-08-30

Family

ID=44246811

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13104921.1A HK1177745A1 (zh) 2009-12-17 2013-04-23 作為 酶抑制劑的雜芳基芳基三唑衍生物

Country Status (36)

Country Link
US (2) US8501795B2 (zh)
EP (1) EP2513106B1 (zh)
JP (1) JP6035149B2 (zh)
KR (1) KR101779629B1 (zh)
CN (1) CN102753550B (zh)
AR (1) AR079496A1 (zh)
AU (1) AU2010333438B2 (zh)
BR (1) BR112012014486A2 (zh)
CA (1) CA2783728C (zh)
CO (1) CO6602117A2 (zh)
CR (1) CR20120318A (zh)
CY (1) CY1116361T1 (zh)
DK (1) DK2513106T3 (zh)
DO (1) DOP2012000169A (zh)
EA (1) EA021606B1 (zh)
ES (1) ES2442179T3 (zh)
GE (1) GEP20146201B (zh)
GT (1) GT201200193A (zh)
HK (1) HK1177745A1 (zh)
HR (1) HRP20131210T1 (zh)
IL (1) IL220328A (zh)
MA (1) MA33923B1 (zh)
MX (1) MX2012006715A (zh)
MY (1) MY156520A (zh)
NZ (1) NZ600365A (zh)
PL (1) PL2513106T3 (zh)
PT (1) PT2513106E (zh)
RS (1) RS53101B (zh)
SG (1) SG181672A1 (zh)
SI (1) SI2513106T1 (zh)
SM (1) SMT201400009B (zh)
TN (1) TN2012000278A1 (zh)
TW (1) TWI487705B (zh)
UA (1) UA107950C2 (zh)
WO (1) WO2011072697A1 (zh)
ZA (1) ZA201204420B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI481607B (zh) 2009-12-17 2015-04-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑的２－芳基咪唑衍生物
TWI487705B (zh) * 2009-12-17 2015-06-11 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物
TWI485151B (zh) 2009-12-17 2015-05-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物
CA2824047C (en) 2011-01-11 2019-06-18 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
EP2675791B1 (en) 2011-02-18 2016-02-17 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
CA2846758C (en) * 2011-09-19 2017-09-12 F. Hoffmann-La Roche Ag Triazolopyridine compounds as pde10a inhibitors
WO2013127817A1 (en) 2012-02-27 2013-09-06 H. Lundbeck A/S Imidazole derivatives as pde10a enzyme inhibitors
BR112014026828A2 (pt) * 2012-05-30 2017-06-27 Hoffmann La Roche compostos de triazolo como inibidores de pde10
EP2861596B1 (en) * 2012-06-19 2019-03-20 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9284302B2 (en) 2012-11-15 2016-03-15 Merck Sharp & Dohme Corp. Cyclobutyl benzimidazoles as PDE 10 inhibitors
JP2017501135A (ja) * 2013-11-28 2017-01-12 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ イミダゾール誘導体
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
CN114671874B (zh) * 2021-08-30 2024-02-02 济南爱思医药科技有限公司 一种具有抗肿瘤活性的茶碱乙酸衍生物及其制备方法与应用
WO2023064458A1 (en) * 2021-10-13 2023-04-20 Yale University Selective jak2 inhibitors and methods of use

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1462521A (en) 1974-02-11 1977-01-26 Wyeth John & Brother Ltd Triazole derivatives
GB8307865D0 (en) 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US5571775A (en) 1994-07-11 1996-11-05 Dowelanco N-aryl[1,2,4]triazolo[1,5-a]pyridine-2-sulfonamide herbicides
US6699853B2 (en) 1997-06-16 2004-03-02 Hoechst Schering Agrevo Gmbh 4-haloalkyl-3-heterocyclylpyridines, 4-haloalkyl-5-heterocyclyl-pyrimidines and 4-trifluoromethyl-3-oxadiazolylpyridines, processes for their preparation, compositions comprising them, and their use as pesticides
SE9802937D0 (sv) 1998-09-01 1998-09-01 Astra Pharma Prod Novel compounds
US20030032579A1 (en) 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
IL149106A0 (en) 2001-04-20 2002-11-10 Pfizer Prod Inc Therapeutic use of selective pde10 inhibitors
FR2824065A1 (fr) 2001-04-26 2002-10-31 Neuro3D Composes inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations
DE60324449D1 (de) 2002-10-30 2008-12-11 Via Pharmaceuticals Inc Inhibitoren der phosphodiesterase der zyklischen n, und deren verwendung in therapie
WO2005003129A1 (en) 2003-06-30 2005-01-13 Altana Pharma Ag Pyrrolodihydroisoquinolines as pde10 inhibitors
US20070105840A1 (en) 2003-06-30 2007-05-10 Altana Pharma Ag Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors
EP1651251A4 (en) 2003-07-31 2008-06-18 Bayer Pharmaceuticals Corp METHOD FOR THE TREATMENT OF DIABETES AND RELATED DISEASES USING PDE 10A INHIBITORS
BRPI0507839A (pt) 2004-02-18 2007-05-08 Pfizer Prod Inc derivados tetraidroisoquinolinil de quinazolina e isoquinolina
FR2870539B1 (fr) 2004-05-19 2006-08-04 Greenpharma Sa Sa Nouvelles methodes et medicaments
BRPI0511854A (pt) 2004-06-07 2008-01-15 Pfizer Prod Inc inibição de fosfodiestearase 10 como tratamento para condições relacionados com a obesidade e relacionadas a sìndrome metabólica
US20060019975A1 (en) 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
CA2578996A1 (en) 2004-09-03 2006-03-16 Memory Pharmaceuticals Corporation 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
NL2000397C2 (nl) * 2006-01-05 2007-10-30 Pfizer Prod Inc Bicyclische heteroarylverbindingen als PDE10 inhibitoren.
US20080090834A1 (en) * 2006-07-06 2008-04-17 Pfizer Inc Selective azole pde10a inhibitor compounds
ES2392553T3 (es) * 2006-07-10 2012-12-11 H. Lundbeck A/S Derivados (3-aril-piperazina-1-ilo) de 6,7-dialcoxiquinazolina, 6,7-dialcoxiftalazina y 6,7-dialcoxiisoquinolina
US7897619B2 (en) 2007-07-17 2011-03-01 Amgen Inc. Heterocyclic modulators of PKB
GB0800411D0 (en) 2008-01-10 2008-02-20 Glaxo Group Ltd Novel compounds
TWI485151B (zh) 2009-12-17 2015-05-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物
TWI481607B (zh) 2009-12-17 2015-04-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑的２－芳基咪唑衍生物
TWI487705B (zh) * 2009-12-17 2015-06-11 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物
NZ705135A (en) * 2010-05-26 2017-10-27 Sunovion Pharmaceuticals Inc Heteroaryl compounds and methods of use thereof

Also Published As

Publication number Publication date
AU2010333438B2 (en) 2016-03-10
PT2513106E (pt) 2014-01-20
MX2012006715A (es) 2012-07-03
MA33923B1 (fr) 2013-01-02
SG181672A1 (en) 2012-07-30
ZA201204420B (en) 2013-09-25
US20130281459A1 (en) 2013-10-24
PL2513106T3 (pl) 2014-09-30
GT201200193A (es) 2013-09-26
CN102753550B (zh) 2015-03-25
TWI487705B (zh) 2015-06-11
TN2012000278A1 (en) 2013-12-12
AR079496A1 (es) 2012-02-01
EP2513106A1 (en) 2012-10-24
CA2783728C (en) 2018-06-12
US8785653B2 (en) 2014-07-22
SI2513106T1 (sl) 2014-01-31
US20120309764A1 (en) 2012-12-06
IL220328A0 (en) 2012-08-30
EA201290517A1 (ru) 2012-12-28
AU2010333438A1 (en) 2012-06-21
SMT201400009B (it) 2014-03-07
CN102753550A (zh) 2012-10-24
CO6602117A2 (es) 2013-01-18
WO2011072697A1 (en) 2011-06-23
DK2513106T3 (da) 2014-01-13
JP6035149B2 (ja) 2016-11-30
TW201130834A (en) 2011-09-16
CA2783728A1 (en) 2011-06-23
NZ600365A (en) 2013-10-25
BR112012014486A2 (pt) 2017-04-04
IL220328A (en) 2014-12-31
CR20120318A (es) 2012-08-16
US8501795B2 (en) 2013-08-06
CY1116361T1 (el) 2017-02-08
ES2442179T3 (es) 2014-02-10
EA021606B1 (ru) 2015-07-30
JP2013514286A (ja) 2013-04-25
HRP20131210T1 (hr) 2014-01-17
UA107950C2 (en) 2015-03-10
DOP2012000169A (es) 2012-12-15
EP2513106B1 (en) 2013-11-06
KR20120113215A (ko) 2012-10-12
KR101779629B1 (ko) 2017-09-18
RS53101B (en) 2014-06-30
MY156520A (en) 2016-02-26
GEP20146201B (en) 2014-11-25

Similar Documents

Publication Publication Date Title
HK1177745A1 (zh) 作為 酶抑制劑的雜芳基芳基三唑衍生物
IL209834A (en) Phenylimidazole derivatives as a10pde enzyme sequences
HK1177208A1 (zh) 作為 酶抑制劑的雜芳族苯基咪唑衍生物
HK1177739A1 (zh) 作為 酶抑制劑的 -芳基咪唑衍生物
IL221823A (en) Pipridine-4-Il-Aztidine Derivatives as Jack 1 Suppressors
AP3342A (en) Imidazole derivatives as PDE10A enzyme inhibitors
ZA201109271B (en) Novel phenylimidazole derivative as pde10a enzyme inhibitor
HK1171220A1 (zh) 用作酪蛋白激酶抑制劑的咪唑衍生物
EP2381777A4 (en) AZAINDOL DERIVATIVES AS KINASEHEMMER
EP2632461A4 (en) ISOINDOLINONE COMPOUNDS USEFUL AS PDE INHIBITORS 10
EP2493308A4 (en) ARYL AMINOPYRIDINE INHIBITORS OF PDE10
HK1189593A1 (zh) 作為 酶抑制劑的咪唑衍生物
HK1171446A1 (zh) 作為 酶抑制劑的苯基咪唑衍生物

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211212